CDNA
Price
$13.81
Change
+$0.71 (+5.42%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
697.27M
55 days until earnings call
ELUT
Price
$1.88
Change
-$0.13 (-6.47%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
85.21M
73 days until earnings call
Interact to see
Advertisement

CDNA vs ELUT

Header iconCDNA vs ELUT Comparison
Open Charts CDNA vs ELUTBanner chart's image
CareDx
Price$13.81
Change+$0.71 (+5.42%)
Volume$41.51K
Capitalization697.27M
Elutia
Price$1.88
Change-$0.13 (-6.47%)
Volume$24.72K
Capitalization85.21M
CDNA vs ELUT Comparison Chart in %
Loading...
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDNA vs. ELUT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDNA is a Buy and ELUT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CDNA: $13.10 vs. ELUT: $2.01)
Brand notoriety: CDNA and ELUT are both not notable
CDNA represents the Medical Specialties, while ELUT is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CDNA: 79% vs. ELUT: 260%
Market capitalization -- CDNA: $697.27M vs. ELUT: $85.21M
CDNA [@Medical Specialties] is valued at $697.27M. ELUT’s [@Medical/Nursing Services] market capitalization is $85.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.57B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDNA’s FA Score shows that 0 FA rating(s) are green whileELUT’s FA Score has 0 green FA rating(s).

  • CDNA’s FA Score: 0 green, 5 red.
  • ELUT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CDNA and ELUT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDNA’s TA Score shows that 4 TA indicator(s) are bullish while ELUT’s TA Score has 4 bullish TA indicator(s).

  • CDNA’s TA Score: 4 bullish, 3 bearish.
  • ELUT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CDNA is a better buy in the short-term than ELUT.

Price Growth

CDNA (@Medical Specialties) experienced а -0.08% price change this week, while ELUT (@Medical/Nursing Services) price change was -13.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.22%. For the same industry, the average monthly price growth was +6.83%, and the average quarterly price growth was +11.96%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.21%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +24.78%.

Reported Earning Dates

CDNA is expected to report earnings on Oct 30, 2025.

ELUT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Medical Specialties (+0.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-0.21% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDNA($697M) has a higher market cap than ELUT($85.2M). CDNA YTD gains are higher at: -38.814 vs. ELUT (-46.257). ELUT has higher annual earnings (EBITDA): -14.01M vs. CDNA (-23.07M). CDNA has more cash in the bank: 186M vs. ELUT (8.5M). ELUT (28.2M) and CDNA (29.1M) have identical debt. CDNA has higher revenues than ELUT: CDNA (341M) vs ELUT (23.7M).
CDNAELUTCDNA / ELUT
Capitalization697M85.2M818%
EBITDA-23.07M-14.01M165%
Gain YTD-38.814-46.25784%
P/E Ratio12.48N/A-
Revenue341M23.7M1,439%
Total Cash186M8.5M2,188%
Total Debt29.1M28.2M103%
FUNDAMENTALS RATINGS
CDNA: Fundamental Ratings
CDNA
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDNAELUT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RICFY15.820.26
+1.67%
Recordati Industria Chimica e Farmaceutica S.p.A.
NLCP13.800.09
+0.66%
NewLake Capital Partners, Inc.
NDATF0.01N/A
N/A
NDATALYZE CORP.
LFLRF0.38N/A
-1.28%
LaFleur Minerals Inc.
YUEIY8.21-0.60
-6.77%
Yue Yuen Industrial (Holdings) Ltd

CDNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDNA has been loosely correlated with NTRA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CDNA jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDNA
1D Price
Change %
CDNA100%
+2.91%
NTRA - CDNA
42%
Loosely correlated
-0.58%
BLFS - CDNA
39%
Loosely correlated
+3.31%
VCYT - CDNA
38%
Loosely correlated
+2.94%
ABT - CDNA
36%
Loosely correlated
+0.48%
LMAT - CDNA
35%
Loosely correlated
+2.65%
More

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and PDEX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and PDEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
+1.01%
PDEX - ELUT
23%
Poorly correlated
-1.57%
SMTI - ELUT
23%
Poorly correlated
+1.58%
TWST - ELUT
23%
Poorly correlated
-1.42%
HSDT - ELUT
22%
Poorly correlated
+1.78%
CDNA - ELUT
22%
Poorly correlated
+2.91%
More